There is a lower risk of 1-year ventricular arrhythmias or death in women with nonischemic cardiomyopathy and an implantable cardioverter defibrillator (ICD) compared with men.

LONDON--(BUSINESS WIRE)--Technavio’s global implantable cardioverter defibrillators (ICD) market research report forecasts the market to grow at a CAGR of almost 2% during the forecast period. The ...

MINNEAPOLIS--(BUSINESS WIRE)-- Medtronic, Inc. (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Protecta™ portfolio of implantable cardioverter-defibrillators (ICDs) ...

The global implantable defibrillator market is projected to grow at a CAGR of ~7% during the forecast period. The growth is ...

The FDA has issued a safety alert for several models of Boston Scientific’s Endotak Reliance defibrillation leads after identifying a serious defect linked to 16 deaths and 386 injuries. The leads, ...

Almost exactly a year after beginning a recall of some of its implantable defibrillator devices that were found to potentially emit electrical pulses below their programmed strength, Medtronic has ...

Medtronic has received U.S. regulatory approval to sell a new implantable defibrillator that can be placed outside of the heart and veins to treat SCA — sudden cardiac arrest — an electrical problem ...

BALTIMORE (AP) - Dr. Morton Mower, a former Maryland-based cardiologist who helped invent an automatic implantable defibrillator that has helped countless heart patients live longer and healthier, has ...

The researchers found that women with nonischemic cardiomyopathy and an implantable cardioverter defibrillator had a lower risk for ventricular tachyarrhythmias or death compared to men. HealthDay ...